| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |